DURECT

$1.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-5.41%) Today

-$0.01 (-0.57%) As of 8:09 PM UTC after-hours

Why Robinhood?

You can buy or sell DURECT and other stocks, options, and ETFs commission-free!

About DRRX

DURECT Corp. focuses in advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator.

CEO

James E. Brown

Employees

Headquarters

Cupertino, California

Founded

1998

Market Cap

401.83M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.01M

High Today

$1.84

Low Today

$1.75

Open Price

$1.83

Volume

771.04K

52 Week High

$2.96

52 Week Low

$1.52

Analyst Ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

DRRX Earnings

-$0.05

-$0.01

$0.03

$0.07

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 10, After Hours